BridgeBio · 5 hours ago
Associate Director, Marketing - Patient
BridgeBio is a pioneering biotech company focused on developing life-changing medicines for patients with unmet needs. The Associate Director, Patient Marketing, will play a crucial role in the commercialization of a key asset by driving cross-functional collaboration and executing marketing strategies to support patients during the product launch.
BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
Responsibilities
Serve as a commercial member on the Product Teams, embedding the market needs into cross functional planning
Drive innovative tactics and address untapped opportunities
Lead patient brand planning, messaging and claims work
Help identify and support the development of patients and caregivers for patient ambassador programming
Uncover and address unmet needs by seeking insights to utilize to improve/refine launch planning and execution
Lead agile, cross-functional team to develop/launch innovative patient marketing campaigns that will inspire behavioral change and drive brand growth; ensure aligned launch execution across functions
Develop and track metrics to measure and ensure the success of marketing/promotional programs
Coordinate with digital marketing to build an effective customer engagement ecosystem
Partner with Value and Access to help develop programming to support patient access and adherence
Partner with regional teams to ensure diverse commercial insights are brought into the planning process, be the commercial voice advocating for these views
Partner closely with advocacy teams to develop tactics that will help educate and support patients
Develop targeted measurement plans to help evaluate effectiveness of patient tactics and prioritization of efforts
Work cross-functionally with agency partners, sales, commercial operations, brand analytics, IT, MCM, etc
Qualification
Required
5+ years of commercial biotech or pharmaceutical experience, with at least three years in Marketing
Demonstrated ability to develop and action insights from complex clinical data and market research
Understanding of the drug development process, especially regarding opportunities for differentiation and value demonstration
Excellent oral, written, and presentation skills
Passionate about serving patients suffering from Genetic diseases
Proven self-starter, able to work independently and as part of a team
Able to handle full workload across multiple projects
Collaborates seamlessly across functions to build effective working relationships and align strategy and execution
High level of self-awareness and understanding of the importance of self-monitoring behavior for continuous improvement
True entrepreneurial spirit – BridgeBio was built to do things differently and address the needs of underserved populations, driven by science and unrelenting passion for patients
Ability to travel (~20%) is required
Preferred
Successful launch experience in a competitive market
Rare disease experience
Benefits
401K with 100% employer match on first 3% & 50% on the next 2%
Employee stock purchase program
Pre-tax commuter benefits
Referral program with $2,500 award for hired referrals
Comprehensive health care with 100% premiums covered - no cost to you and dependents
Mental health support via Spring Health (6 therapy sessions & 6 coaching sessions)
Hybrid work model - employees have the autonomy in where and how they do their work
Unlimited flexible paid time off - take the time that you need
Paid parental leave - 4 months for birthing parents & 2 months for non-birthing parents
Flex spending accounts & company-provided group term life & disability
Subsidized lunch via Forkable on days worked from our office
We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, Spring Health & BetterUp Coaching
We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities
Company
BridgeBio
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
Funding
Current Stage
Public CompanyTotal Funding
$4.9BKey Investors
Blue OwlQatar Investment AuthorityKohlberg Kravis Roberts
2026-01-16Post Ipo Debt· $550M
2025-02-25Post Ipo Debt· $500M
2024-03-04Post Ipo Equity· $250M
Recent News
BioWorld Financial Watch
2026-01-17
Company data provided by crunchbase